Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction

Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction

George E Fragoulis,1,* Stergios Soulaidopoulos,2,* Petros P Sfikakis,1 Theodoros Dimitroulas,3 George D Kitas4,5 1Rheumatology Unit, Joint Rheumatology Program, Medical School, First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, “Laiko&rd...

Full description

Bibliographic Details
Main Authors:	Fragoulis GE, Soulaidopoulos S, Sfikakis PP, Dimitroulas T, Kitas GD
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-05-01
Series:	Journal of Inflammation Research
Subjects:	atherosclerosis cardiovascular disease biologic agents interleukins inflammatory disorders
Online Access:	https://www.dovepress.com/effect-of-biologics-on-cardiovascular-inflammation-mechanistic-insight-peer-reviewed-fulltext-article-JIR

Similar Items

The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
by: Stergios Soulaidopoulos, et al.
Published: (2018-02-01)

Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases
by: George D. Kitas, et al.
Published: (2012-09-01)

Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system
by: Agnieszka Czyżewska-Buczyńska, et al.
Published: (2014-06-01)

Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system
by: Agnieszka Czyżewska-Buczyńska, et al.
Published: (2014-06-01)

Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation
by: Psarros Costas, et al.
Published: (2015-04-01)

Cytokines at the Interplay Between Asthma and Atherosclerosis?
by: Danila Gurgone, et al.
Published: (2020-03-01)

Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
by: Corey A. Scipione, et al.
Published: (2015-12-01)

Assessment of cardiovascular risk from the use of an interleukin-1 inhibitor in patients with severe tophaceous gout
by: M. S. Eliseev, et al.
Published: (2016-03-01)

Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease
by: Tanushree Agrawal, et al.
Published: (2021-06-01)

Potential Immunological Links Between Psoriasis and Cardiovascular Disease
by: Aparna P. Sajja, et al.
Published: (2018-06-01)

Research advances in relationship between chronic periodontitis and cardiovascular diseases
by: WU Yafei, et al.
Published: (2017-11-01)

Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
by: Daniel J. DeMizio, et al.
Published: (2019-12-01)

Periodontal disease and inflammatory blood cytokines in patients with stable coronary artery disease
by: Cassio KAMPITS, et al.

Insights into pathophysiology of smoke-related cardiovascular disease
by: Salvatore De Rosa, et al.
Published: (2016-01-01)

Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
by: Yu En, et al.
Published: (2018-05-01)

New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases
by: Liliana Maria Sanmarco, et al.
Published: (2018-01-01)

Cardiovascular Effects of Saffron: An Evidence-Based Review
by: Maryam Kamalipour, et al.
Published: (2011-06-01)

Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats Efeitos cardiovasculares e hematológicos produzidos pelo tratamento crônico com etoricoxib em ratos normotensos
by: Nilo César do Vale Baracho, et al.
Published: (2009-06-01)

The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice
by: Geerte Hoeke, et al.
Published: (2017-08-01)

Association of chest pain and risk of cardiovascular disease with coronary atherosclerosis in patients with inflammatory joint diseases
by: Silvia eRollefstad, et al.
Published: (2015-11-01)

High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease1
by: Meliana Riwanto, et al.
Published: (2013-12-01)

Common Variants in <i>IL-20</i> Gene are Associated with Subclinical Atherosclerosis, Cardiovascular Risk Factors and IL-20 Levels in the Cohort of the Genetics of Atherosclerotic Disease (GEA) Mexican Study
by: Javier Angeles-Martínez, et al.
Published: (2020-01-01)

Cardiovascular Effects of Saffron: An Evidence-Based Review
by: Shahin Akhondzadeh, et al.
Published: (2011-05-01)

Inflammation and cardiovascular disease: From mechanisms to therapeutics
by: Abdulhamied Alfaddagh, et al.
Published: (2020-12-01)

Current evidence and biological plausibility linking periodontitis to atherosclerotic cardiovascular disease
by: Koichi Tabeta, DDS,PhD, et al.
Published: (2014-08-01)

Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation
by: Zhao Gao, et al.
Published: (2021-09-01)

The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease
by: Kimmie B. Colmorten, et al.
Published: (2019-09-01)

Role of Endoplasmic Reticulum Stress, Autophagy, and Inflammation in Cardiovascular Disease
by: Cheng Zhang, et al.
Published: (2017-05-01)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
by: Aikaterini Arida, et al.
Published: (2018-06-01)

The Role of Inflammation in Cardiovascular Disease in HIV-Infected Patients
by: Rygelski, Marian Mikaela, et al.
Published: (2017)

Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk?
by: M. V. Zykov, et al.
Published: (2021-09-01)

Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
by: Oleg Kandarakov, et al.
Published: (2020-10-01)

Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions
by: Jéssica Cavalcante dos Santos, et al.
Published: (2018-05-01)

The expression of interleukin-1 receptor type 1 and 11 in monocytes and myelocytic leukaemic cells
by: Flagg, Angela Sally.
Published: (2018)

The expression of interleukin-1 receptor type 1 and 11 in monocytes and myelocytic leukaemic cells.
by: Flagg, Angela Sally.
Published: (2018)

Research Progress on the Relationship between Atherosclerosis and Inflammation
by: Yuhua Zhu, et al.
Published: (2018-08-01)

Osteoprotegerin is a new marker of cardiovascular diseases
by: A F Verbovoy, et al.
Published: (2017-04-01)

Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A
by: Johannes Nordlohne, MA, et al.
Published: (2018-02-01)

Ideal cardiovascular health and the subclinical impairments of cardiovascular diseases: a cross-sectional study in central south China
by: Ya-Qin Wang, et al.
Published: (2017-10-01)

Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease
by: Brena F. Sena, et al.
Published: (2018-01-01)